Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study

MT NewswiresJan 21 09:28 ET

Amylyx Pharmaceuticals Announces FDA Lifts Clinical Hold On AMX0114 Phase 1 Clinical Trial In Treatment Of Amyotrophic Lateral Sclerosis

BenzingaJan 21 09:01 ET

Express News | Amylyx Pharmaceuticals Inc - Anticipates Early Cohort Data From Lumina in 2025

ReutersJan 21 09:00 ET

Express News | Amylyx Pharmaceuticals Inc - to Move Forward With Trial Sites Across North America

ReutersJan 21 09:00 ET

Express News | Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on Amx0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

ReutersJan 21 09:00 ET

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

BusinesswireJan 21 09:00 ET